4 ш - перевести

Lotilaner Market set to hit $938.2 million by 2035

Industry revenue for Lotilaner is estimated to rise to $938.2 million by 2035 from $432.2 million of 2024. The revenue growth of market players is expected to average at 7.3% annually for the period 2024 to 2035.

Lotilaner is critical across several key applications including veterinary flea & tick control, parasite resistance research, agricultural pest management and wildlife protection. The report unwinds growth & revenue expansion opportunities at Lotilaner’s Product Application, User Types, Dosage Type and Sales Channel including industry revenue forecast.

Industry Leadership and Competitive Landscape

The Lotilaner market is characterized by intense competition, with a number of leading players such as Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Merck & Co. Inc., Zoetis Inc., Virbac, Perrigo Company plc, Heska Corp, Ceva Sante Animale, Vetoquinol SA, Dechra Pharmaceuticals PLC, Chanelle Pharma and N-Vet AB..
The Lotilaner market is projected to expand substantially, driven by surge in pet ownership and growing awareness of zoonotic diseases. This growth is expected to be further supported by Industry trends like Technological Advancements in Veterinary Medicine.

Moreover, the key opportunities, such as veterinary medicine advancements, strategic partnerships in pharma and emergence of pet-centric consumerism, are anticipated to create revenue pockets in major demand hubs including U.S., Germany, UK, Canada and Australia.

Regional Shifts and Evolving Supply Chains

North America and Europe are the two most active and leading regions in the market. With challenges like regulatory challenges and market competition, Lotilaner market’s supply chain from raw material suppliers / primary producers / secondary manufacturers to end user is expected to evolve & expand further; and industry players will make strategic advancement in emerging markets including Brazil, India and South Africa for revenue diversification and TAM expansion.

Detailed Analysis - https://datastringconsulting.c....om/industry-analysis

Download Free Sample - https://datastringconsulting.c....om/downloadsample/lo

About DataString Consulting

DataString Consulting delivers a comprehensive suite of market research and business intelligence solutions for both B2B and B2C sectors all under one roof. From precise, targeted insights to fully customized market research reports, our services are built to align with each client’s strategic goals. With a leadership team boasting over 30 years of combined experience serving Fortune 500 companies, we offer high-impact research and data services across global markets.

Our service portfolio is designed to support organizations of all sizes. As pioneers of a collaborative and cost-efficient model, we are shaping a sustainable ecosystem where market research firms, consultancies, and corporate teams can access reliable, decision-ready insights—without the overhead of traditional research operations.

Contact:
Mr. Mark Lawson
DataString Consulting
mlawson@datastringconsulting.com
sales@datastringconsulting.com

Lotilaner Market Report 2025 | Trends, Analysis & Forecast

Lotilaner Market to grow from $432M in 2024 to $659M by 2030 with 7.3% CAGR; Pet owners and Farmers User Types to capture larger market share.